RESUMEN
El presente artículo presenta un panorama general de la base jurídica introducida por el Reglamento General de Protección de Datos (RGPD) en relación con la protección de los datos genéticos. El objetivo de este artículo es examinar críticamente la definición del término "datos genéticos" que proporciona el Reglamento con el fin de analizar la protección que este instrumento otorga a tal categoría especial de datos personales. El artículo ofrece una visión general de las partes de tal definición que la autora considera "problemáticas" para una adecuada y suficiente protección de este tipo de datos y resume las cuestiones planteadas por el enfoque adoptado por el RGPD para la protección de los datos genéticos. La finalidad principal de este artículo es, por tanto, contribuir a un debate más amplio que aborde los desafíos identificados y permita encontrar formas viables de proteger esta categoría única de datos personales
The present article presents an overview of the legal background introduced by the General Data Protection Regulation (GDPR) with regard to the protection of genetic data. The aim of this article is to critically examine the definition of the term "genetic data" provided by the General Data Protection Regulation in order to achieve a better understanding of the protection afforded to this special category of personal data by the Regulation. The article offers an overview of the parts of such definition that the author considers "problematic" and summarizes the questions raised by the General Data Protection regulation's approach to the protection of genetic data. The main objective of this article is therefore, to contribute to a wider debate that would address the identified challenges and bring us closer to finding viable ways of protecting this unique category of personal data
Asunto(s)
Humanos , Seguridad Computacional/legislación & jurisprudencia , Seguridad Computacional/normas , Bases de Datos Genéticas/legislación & jurisprudencia , Bases de Datos Genéticas/normasRESUMEN
When analyzing sequencing reads, it is important to distinguish between putative correct and wrong bases. An open question is how a PHRED quality value is capable of identifying the miscalled bases and if there is a quality cutoff that allows mapping of most errors. Considering the fact that a low quality value does not necessarily indicate a miscalled position, we decided to investigate if window-based analyses of quality values might better predict errors. There are many reasons to look for a perfect window in DNA sequences, such as when using SAGE technique, looking for BLAST seeding and clustering sequences. Thus, we set out to find a quality cutoff value that would distinguish non-perfect windows from perfect ones. We produced and compared 846 reads of pUC18 with the published pUC consensus, by local alignment. We then generated a database containing all mismatches, insertions and gaps in order to map real perfect windows. An investigation was made to find the potential to predict perfect windows when all bases in the window show quality values over a given cutoff. We conclude that, in window-based applications, a PHRED quality value cutoff of 7 masks most of the errors without masking real correct windows. We suggest that the putative wrong bases be indicated in lower case, increasing the information on the sequence databases without increasing the size the files.
Asunto(s)
Humanos , Algoritmos , Bases de Datos Genéticas/normas , Genoma Humano , Control de Calidad , Análisis de Secuencia de ADN/normas , Secuencia de Bases , Datos de Secuencia Molecular , Sistemas de Lectura Abierta , Alineación de Secuencia , Programas Informáticos , Análisis de Secuencia de ADN/métodosRESUMEN
The literature about genomics and bioinformatics achievements in high-impact journals such as Nature and Science has raised disproportionate expectations amongst the general public about fast and revolutionary drugs and breakthroughs in biomedicine. However, the yield obtained by database mining activities has been modest, as reported in the February 2001 issues of these journals featuring the completion of human genome draft sequences by the Human Genome Project Consortium and the company Celera. I have compared changes in rethoric employed by molecular biologists in 2001 and in April 2003, when the final sequence was announced. The comparison suggests that researchers are concerned about the sustainability of societys investment in this field, though not explicitly.